TECH Return on Tangible Equity | BIO-TECHNE Corp

BIO-TECHNE Corp (TECH) Return on Tangible Equity

2026-06-30: Return Tang Equity 21.93%.
2026-03-31: Return Tang Equity 13.90%.
2025-12-31: Return Tang Equity 11.66%.
2025-09-30: Return Tang Equity 12.25%.

Complete source-backed return tang equity history.

Available history: 2009-06-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	21.93%
2026-03-31	13.90%
2025-12-31	11.66%
2025-09-30	12.25%
2025-06-30	12.83%
2025-03-31	21.74%
2024-12-31	24.22%
2024-09-30	22.49%
2024-06-30	28.54%
2024-03-31	37.61%
2023-12-31	49.20%
2023-09-30	52.26%
2023-06-30	49.03%
2023-03-31	55.53%
2022-12-31	63.46%
2022-09-30	90.43%
2022-06-30	73.36%
2022-03-31	62.96%
2021-12-31	64.92%
2021-09-30	79.31%
2021-06-30	110.88%
2021-03-31	60.66%
2020-12-31	60.44%
2020-09-30	124.11%
2020-06-30	168.18%
2020-03-31	532.45%
2019-12-31	495.33%
2019-09-30	-77.86%
2019-06-30	-65.58%
2019-03-31	-79.56%
2018-12-31	-44.18%
2018-09-30	-56.00%
2018-06-30	362.09%
2018-03-31	2925.03%
2017-12-31	-386.23%
2017-09-30	-92.87%
2017-06-30	-93.43%
2017-03-31	-51.28%
2016-12-31	-51.17%
2016-09-30	-57.81%
2016-06-30	71.92%
2016-03-31	102.20%
2015-12-31	84.84%
2015-09-30	124.99%
2015-06-30	65.91%
2015-03-31	79.05%
2014-12-31	109.27%
2014-09-30	59.46%
2014-06-30	20.74%
2014-03-31	20.98%
2013-12-31	22.55%
2013-09-30	23.70%
2013-06-30	18.37%
2013-03-31	18.77%
2012-12-31	19.56%
2012-09-30	20.18%
2012-06-30	20.71%
2012-03-31	22.26%
2011-12-31	24.32%
2011-09-30	24.99%
2011-06-30	25.11%
2011-03-31	20.36%
2010-12-31	21.58%
2010-09-30	22.02%
2010-06-30	23.13%

Annual Return Tang Equity

Date	Return Tang Equity
2026-06-30	21.93%
2025-06-30	12.83%
2024-06-30	28.54%
2023-06-30	49.03%
2022-06-30	73.36%
2021-06-30	110.88%
2020-06-30	168.18%
2019-06-30	-65.58%
2018-06-30	362.09%
2017-06-30	-93.42%
2016-06-30	71.92%
2015-06-30	65.91%
2014-06-30	20.74%
2013-06-30	18.37%
2012-06-30	20.71%
2011-06-30	25.11%
2010-06-30	23.13%
2009-06-30	24.57%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78